The diagnostic and prognostic value of chromogranin A and synaptophysin in gastroenteropancreatic neuroendocrine tumors
10.3760/cma.j.issn.0254-1432.2012.01.007
- VernacularTitle:嗜铬素A和突触素对胃肠胰腺神经内分泌肿瘤诊断及预后的临床价值
- Author:
Bixing YE
;
Lin LIN
- Publication Type:Journal Article
- Keywords:
Gastrointestinal neoplasms;
Pancreatic neoplasms;
Carcinoma,neuroendocrine;
Synapsins;
Chromogranins;
Prognosis
- From:
Chinese Journal of Digestion
2012;32(1):29-32
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the expression and clinical significance of chromogranin A (CgA) and synaptophysin (Syn) in gastroenteropancreatic neuroendocrine tumors (GEP-NET).MethodsThe data of sixty-six GEP-NET patients treated in the First Affiliated Hospital of Nanjing Medical University were collected between Jan.2003 and May 2009.The expression of CgA and Syn in the tissue of GEP-NET was detected by immunohistochemistry, and its association with clinicopathological characteristics and prognosis of GEP-NET were analyzed.Results In these 66 patients,the positive rate of Syn (87.9％,58/66) was higher than that of CgA (71.3％,47/66,x2 =5.63,P=0.02).CgA and Syn were simultaneously expressed in 64.6％ patients (42/66).In the tissues of GEP-NET,the expression of CgA was related with lymph node metastasis and TNM stages,not related with patients' gender,age,tumor location,function,degree of differentiation,tumor size,infiltration and distant metastasis. Syn was not related with all the above clinicopathological parameters.Three-year survival rate in CgA negative group (47％) was significantly lower than that in positive group (78％,x2 =0.00,P=0.01).ConclusionsSyn was more sensitive than CgA in the diagnosis of GEP-NET.CgA in some extent indicates the prognosis of GEP-NET.
